RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Marla J. Berry to Protein Biosynthesis

This is a "connection" page, showing publications Marla J. Berry has written about Protein Biosynthesis.
Connection Strength

2.262
  1. Squires JE, Stoytchev I, Forry EP, Berry MJ. SBP2 binding affinity is a major determinant in differential selenoprotein mRNA translation and sensitivity to nonsense-mediated decay. Mol Cell Biol. 2007 Nov; 27(22):7848-55.
    View in: PubMed
    Score: 0.287
  2. Stoytcheva Z, Tujebajeva RM, Harney JW, Berry MJ. Efficient incorporation of multiple selenocysteines involves an inefficient decoding step serving as a potential translational checkpoint and ribosome bottleneck. Mol Cell Biol. 2006 Dec; 26(24):9177-84.
    View in: PubMed
    Score: 0.268
  3. Small-Howard AL, Berry MJ. Unique features of selenocysteine incorporation function within the context of general eukaryotic translational processes. Biochem Soc Trans. 2005 Dec; 33(Pt 6):1493-7.
    View in: PubMed
    Score: 0.254
  4. Hoffmann PR, Berry MJ. Selenoprotein synthesis: a unique translational mechanism used by a diverse family of proteins. Thyroid. 2005 Aug; 15(8):769-75.
    View in: PubMed
    Score: 0.248
  5. Grundner-Culemann E, Martin GW, Tujebajeva R, Harney JW, Berry MJ. Interplay between termination and translation machinery in eukaryotic selenoprotein synthesis. J Mol Biol. 2001 Jul 20; 310(4):699-707.
    View in: PubMed
    Score: 0.187
  6. Tujebajeva RM, Ransom DG, Harney JW, Berry MJ. Expression and characterization of nonmammalian selenoprotein P in the zebrafish, Danio rerio. Genes Cells. 2000 Nov; 5(11):897-903.
    View in: PubMed
    Score: 0.178
  7. Berry MJ, Martin GW, Low SC. RNA and protein requirements for eukaryotic selenoprotein synthesis. Biomed Environ Sci. 1997 Sep; 10(2-3):182-9.
    View in: PubMed
    Score: 0.143
  8. Low SC, Harney JW, Berry MJ. Cloning and functional characterization of human selenophosphate synthetase, an essential component of selenoprotein synthesis. J Biol Chem. 1995 Sep 15; 270(37):21659-64.
    View in: PubMed
    Score: 0.125
  9. Berry MJ, Maia AL, Kieffer JD, Harney JW, Larsen PR. Substitution of cysteine for selenocysteine in type I iodothyronine deiodinase reduces the catalytic efficiency of the protein but enhances its translation. Endocrinology. 1992 Oct; 131(4):1848-52.
    View in: PubMed
    Score: 0.102
  10. Zavacki AM, Mansell JB, Chung M, Klimovitsky B, Harney JW, Berry MJ. Coupled tRNA(Sec)-dependent assembly of the selenocysteine decoding apparatus. Mol Cell. 2003 Mar; 11(3):773-81.
    View in: PubMed
    Score: 0.052
  11. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002 Feb; 23(1):38-89.
    View in: PubMed
    Score: 0.049
  12. Berry MJ, Martin GW, Tujebajeva R, Grundner-Culemann E, Mansell JB, Morozova N, Harney JW. Selenocysteine insertion sequence element characterization and selenoprotein expression. Methods Enzymol. 2002; 347:17-24.
    View in: PubMed
    Score: 0.048
  13. Berry MJ, Tujebajeva RM, Copeland PR, Xu XM, Carlson BA, Martin GW, Low SC, Mansell JB, Grundner-Culemann E, Harney JW, Driscoll DM, Hatfield DL. Selenocysteine incorporation directed from the 3'UTR: characterization of eukaryotic EFsec and mechanistic implications. Biofactors. 2001; 14(1-4):17-24.
    View in: PubMed
    Score: 0.045
  14. Low SC, Grundner-Culemann E, Harney JW, Berry MJ. SECIS-SBP2 interactions dictate selenocysteine incorporation efficiency and selenoprotein hierarchy. EMBO J. 2000 Dec 15; 19(24):6882-90.
    View in: PubMed
    Score: 0.045
  15. Tujebajeva RM, Copeland PR, Xu XM, Carlson BA, Harney JW, Driscoll DM, Hatfield DL, Berry MJ. Decoding apparatus for eukaryotic selenocysteine insertion. EMBO Rep. 2000 Aug; 1(2):158-63.
    View in: PubMed
    Score: 0.044
  16. Grundner-Culemann E, Martin GW, Harney JW, Berry MJ. Two distinct SECIS structures capable of directing selenocysteine incorporation in eukaryotes. RNA. 1999 May; 5(5):625-35.
    View in: PubMed
    Score: 0.040
  17. Low SC, Berry MJ. Knowing when not to stop: selenocysteine incorporation in eukaryotes. Trends Biochem Sci. 1996 Jun; 21(6):203-8.
    View in: PubMed
    Score: 0.033
  18. Berry MJ, Harney JW, Ohama T, Hatfield DL. Selenocysteine insertion or termination: factors affecting UGA codon fate and complementary anticodon:codon mutations. Nucleic Acids Res. 1994 Sep 11; 22(18):3753-9.
    View in: PubMed
    Score: 0.029
  19. Berry MJ, Larsen PR. The role of selenium in thyroid hormone action. Endocr Rev. 1992 May; 13(2):207-19.
    View in: PubMed
    Score: 0.025
  20. Berry MJ, Banu L, Chen YY, Mandel SJ, Kieffer JD, Harney JW, Larsen PR. Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3' untranslated region. Nature. 1991 Sep 19; 353(6341):273-6.
    View in: PubMed
    Score: 0.024
  21. Xu XM, Mix H, Carlson BA, Grabowski PJ, Gladyshev VN, Berry MJ, Hatfield DL. Evidence for direct roles of two additional factors, SECp43 and soluble liver antigen, in the selenoprotein synthesis machinery. J Biol Chem. 2005 Dec 16; 280(50):41568-75.
    View in: PubMed
    Score: 0.016
  22. Xu XM, Carlson BA, Grimm TA, Kutza J, Berry MJ, Arreola R, Fields KH, Shanmugam I, Jeang KT, Oroszlan S, Combs GF, Marx PA, Gladyshev VN, Clouse KA, Hatfield DL. Rhesus monkey simian immunodeficiency virus infection as a model for assessing the role of selenium in AIDS. J Acquir Immune Defic Syndr. 2002 Dec 15; 31(5):453-63.
    View in: PubMed
    Score: 0.013
  23. Toyoda N, Berry MJ, Harney JW, Larsen PR. Topological analysis of the integral membrane protein, type 1 iodothyronine deiodinase (D1). J Biol Chem. 1995 May 19; 270(20):12310-8.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support